WallStreetZenWallStreetZen

NYSE: BIO
Bio Rad Laboratories Inc Stock

Open Broker Account
$399.59-6.20 (-1.53%)
Updated Dec 6, 2022
BIO Price
$399.59
Fair Value Price
N/A
Market Cap
$11.92B
52 Week Low
$344.63
52 Week High
$770.76
P/E
-1.98x
P/B
1.41x
P/S
4.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.80B
Earnings
-$6.03B
Gross Margin
56.1%
Operating Margin
-278.61%
Profit Margin
-215.2%
Debt to Equity
0.43
Operating Cash Flow
$262M
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BIO Overview

Bio-Rad Laboratories, Inc. develops and manufactures specialized technological products for the life science research and clinical diagnostics markets. Offerings include instruments, software, consumables, reagents, and content for cell biology, gene expression, and protein purification. It also offers diagnostic products and systems used in the blood transfusion, diabetes monitoring, autoimmune, and infectious disease testing markets. The company was founded in 1952 and is based in Hercules, California.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BIO is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BIO is good value based on its book value relative to its share price (1.41x), compared to the US Medical Devices industry average (3.71x)
P/B vs Industry Valuation
BIO is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BIO due diligence checks available for Premium users.

Be the first to know about important BIO news, forecast changes, insider trades & much more!

BIO News

Valuation

BIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.98x
Industry
62.36x
Market
21.59x

BIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.41x
Industry
3.71x
BIO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BIO's financial health

Profit margin

Revenue
$680.8M
Net Income
-$164.2M
Profit Margin
-24.1%
BIO's Earnings (EBIT) of -$7.81B... subscribe to Premium to read more.
Interest Coverage Financials
BIO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$12.1B
Liabilities
$3.6B
Debt to equity
0.43
BIO's short-term assets ($3.14B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BIO's short-term assets ($3.14B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BIO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$7.5M
Investing
-$84.9M
Financing
-$8.8M
BIO's operating cash flow ($261.95M)... subscribe to Premium to read more.
Debt Coverage Financials

BIO vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
BIO$11.92B-1.53%-1.98x1.41x
SNN$11.72B-1.05%23.40x2.17x
BRKR$9.78B-0.88%36.12x10.43x
ALGN$14.53B-1.00%28.62x3.93x
SWAV$8.41B-4.28%94.59x23.63x

Bio Rad Laboratories Stock FAQ

What is Bio Rad Laboratories's quote symbol?

NYSE: BIO) Bio Rad Laboratories trades on the NYSE under the ticker symbol BIO. Bio Rad Laboratories stock quotes can also be displayed as NYSE: BIO.

If you're new to stock investing, here's how to buy Bio Rad Laboratories stock.

What is the 52 week high and low for Bio Rad Laboratories (NYSE: BIO)?

(NYSE: BIO) Bio Rad Laboratories's 52-week high was $770.76, and its 52-week low was $344.63. It is currently -48.16% from its 52-week high and 15.95% from its 52-week low.

How much is Bio Rad Laboratories stock worth today?

(NYSE: BIO) Bio Rad Laboratories currently has 29,824,130 outstanding shares. With Bio Rad Laboratories stock trading at $399.59 per share, the total value of Bio Rad Laboratories stock (market capitalization) is $11.92B.

Bio Rad Laboratories stock was originally listed at a price of $13.06 in Dec 31, 1997. If you had invested in Bio Rad Laboratories stock at $13.06, your return over the last 24 years would have been 2,959.65%, for an annualized return of 15.32% (not including any dividends or dividend reinvestments).

How much is Bio Rad Laboratories's stock price per share?

(NYSE: BIO) Bio Rad Laboratories stock price per share is $399.59 today (as of Dec 6, 2022).

What is Bio Rad Laboratories's Market Cap?

(NYSE: BIO) Bio Rad Laboratories's market cap is $11.92B, as of Dec 7, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bio Rad Laboratories's market cap is calculated by multiplying BIO's current stock price of $399.59 by BIO's total outstanding shares of 29,824,130.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.